Together, these data suggest that while co-expression of receptor and ligand in early stage breast cancer may contribute to recurrence, loss of ephrin-A1 ligand in metastatic samples may contribute to invasion, as suggested by laboratory studies [reviewed in [5], [12]]. This evidence concerns the gene EFNA1 and breast cancer.